ACTRN12616000211460已完成未知
The role of exhaled nitric oxide in patients with chronic obstructive pulmonary disease undergoing abdominal surgery: evaluation of postoperative complications
Faculty of Medicine, University of Thessaly0 个研究点目标入组 100 人开始时间: 2016年2月16日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Diagnosis
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 75 Years（—）
- 性别
- All
入选标准
- •Patients scheduled for major abdominal surgeries that were evaluated from an experienced physician were enrolled for the study.
- •The inclusion criteria are:
- •- age 18-75 years
- •- a diagnosis of COPD according to the American Thoracic Society (ATS) criteria in a stable condition and free from exacerbations in the preceding four weeks
- •- ASA physical status II, III, IV
- •- Smoking patients
排除标准
- •Patients with:
- •- other organ failure
- •- inability to cooperate
- •- patients with a recent exacerbation (e.g. requiring hospitalization or oral corticosteroids)
- •- patients with another or coexisting respiratory disorder (e.g. COPD and bronchiectasis)
研究者
相似试验
已完成
不适用
Fractional exhaled nitric oxidein patients with idiopathic pulmonary fibrosisidiopathic pulmonary fibrosisJPRN-UMIN000002120Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine20
已完成
Unknown
Effects of nitric oxide inhalation therapy in the percutaneous ventricular assist device (Impella).JPRN-UMIN000050133Iwate Medical University50
已完成
不适用
To Compare the role of Exhaled Nitric oxide, Spirometry and Asthma Control Test in predicting asthma exacerbationsCTRI/2018/06/014666Dr Kriti Y C154
进行中（未招募）
不适用
The Effects of Nitric Oxide for Inhalation during Left Ventricular Assist Device (LVAD)Implantation. - INOT41acute right ventricular failureMedDRA version: 9.1Level: LLTClassification code 10063082Term: Acute right ventricular failureEUCTR2005-000326-24-DEINO Therapeutics110
进行中（未招募）
1 期
The Effects of Nitric Oxide for Inhalation during Left Ventricular Assist Device (LVAD) Implantation. - INOT41EUCTR2005-000326-24-GBINO Therapeutics110